Cre recombinase-mediated restoration of nigrostriatal dopamine in dopamine-deficient mice reverses hypophagia and bradykinesia.
A line of dopamine-deficient (DD) mice was generated to allow selective restoration of normal dopamine signaling to specific brain regions. These DD floxed stop (DDfs) mice have a nonfunctional Tyrosine hydroxylase (Th) gene because of insertion of a NeoR gene flanked by lox P sites targeted to the first intron of the Th gene. DDfs mice have trace brain dopamine content, severe hypoactivity, and aphagia, and they die without intervention. However, they can be maintained by daily treatment with l-3,4-dihydroxyphenylalanine (L-dopa). Injection of a canine adenovirus (CAV-2) engineered to express Cre recombinase into the central caudate putamen restores normal Th gene expression to the midbrain dopamine neurons that project there because CAV-2 efficiently transduces axon terminals and is retrogradely transported to neuronal cell bodies. Bilateral injection of Cre recombinase into the central caudate putamen restores feeding and normalizes locomotion in DDfs mice. Analysis of feeding behavior by using lickometer cages revealed that virally rescued DDfs mice are hyperphagic and have modified meal structures compared with control mice. The virally rescued DDfs mice are also hyperactive at night, have reduced motor coordination, and are thigmotactic compared with controls. These results highlight the critical role for dopamine signaling in the dorsal striatum for most dopamine-dependent behaviors but suggest that dopamine signaling in other brain regions is important to fine-tune these behaviors. This approach offers numerous advantages compared with previous models aimed at examining dopamine signaling in discrete dopaminergic circuits.
Hnasko
Thomas S
TS
Graduate Program in Neurobiology & Behavior, Department of Biochemistry, and Howard Hughes Medical Institute, University of Washington, Seattle, WA 98195, USA.
Perez
Francisco A
FA
Scouras
Alex D
AD
Stoll
Elizabeth A
EA
Gale
Samuel D
SD
Luquet
Serge
S
Phillips
Paul E M
PE
Kremer
Eric J
EJ
Palmiter
Richard D
RD
D000256:Adenoviridae / Q000235:genetics; D000818:Animals; D001921:Brain / Q000166:cytology / Q000378:metabolism*; D004285:Dogs; D004298:Dopamine / Q000172:deficiency / Q000378:metabolism*; D005247:Feeding Behavior; D001068:Feeding and Eating Disorders / Q000235:genetics* / Q000628:therapy*; D015316:Genetic Therapy / Q000379:methods*; D018476:Hypokinesia / Q000235:genetics* / Q000628:therapy*; D019426:Integrases / Q000235:genetics / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D009043:Motor Activity; D014446:Tyrosine 3-Monooxygenase / Q000235:genetics / Q000378:metabolism; D014764:Viral Proteins / Q000235:genetics / Q000378:metabolism
D014764:Viral Proteins; D014446:Tyrosine 3-Monooxygenase; C045073:Cre recombinase; D019426:Integrases; D004298:Dopamine